@article {244409,
	title = {From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences.},
	journal = {Heliyon},
	volume = {10},
	year = {2024},
	pages = {e30387},
	abstract = {<p>Non-alcoholic fatty liver disease (NAFLD) has become one of the most frequent chronic liver diseases worldwide in recent decades. Metabolic diseases like excessive blood glucose, central obesity, dyslipidemia, hypertension, and liver function abnormalities cause NAFLD. NAFLD significantly increases the likelihood of liver cancer, heart disease, and mortality, making it a leading cause of liver transplants. Non-alcoholic steatohepatitis (NASH) is a more advanced form of the disease that causes scarring and inflammation of the liver over time and can ultimately result in cirrhosis and hepatocellular carcinoma. In this review, we briefly discuss NAFLD{\textquoteright}s pathogenic mechanisms, their progression into NASH and afterward to NASH-related cirrhosis. It also covers disease epidemiology, metabolic mechanisms, glucose and lipid metabolism in the liver, macrophage dysfunction, bile acid toxicity, and liver stellate cell stimulation. Additionally, we consider the contribution of intestinal microbiota, genetics, epigenetics, and ecological factors to fibrosis progression and hepatocellular carcinoma risk in NAFLD and NASH patients.</p>
},
	author = {Samy, Ahmed M and Kandeil, Mohamed A and Dina Sabry and AA Abdel-Ghany and Mahmoud, Mohamed O}
}
